Jurre den Haan

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Jurre den Haan, Tjado H. J. Morrema, Frank D. Verbraak et al. · Acta Neuropathologica Communications · 2018 · 235 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Retinal thickness correlates with parietal cortical atrophy in early‐onset Alzheimer's disease and controls

Jurre den Haan, Sarah F. Janssen, Jacoba A. van de Kreeke et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 140 citations · Full text

Medicine, Neurology, Neuroscience +17

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

Jurre den Haan, Jacoba A. van de Kreeke, Bart N.M. van Berckel et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2019 · 73 citations · Full text

Medicine, Neuroscience, Ophthalmology +17

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics

Jurre den Haan, Tjado H. J. Morrema, Annemieke J.M. Rozemüller et al. · Acta Neuropathologica Communications · 2018 · 72 citations · Full text

Medicine, Neurology, Neuroscience +17

Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies

Frederique J. Hart de Ruyter, Tjado H. J. Morrema, Jurre den Haan et al. · Acta Neuropathologica · 2022 · 64 citations · Full text

Life Sciences, Neurology, Neuroscience +16